Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solid Biosciences

3.41
-0.2850-7.72%
Volume:581.44K
Turnover:1.98M
Market Cap:263.86M
PE:-1.11
High:3.50
Open:3.36
Low:3.33
Close:3.69
Loading ...

Top Midday Gainers

MT Newswires Live
·
19 Feb

BUZZ-Solid Biosciences jumps on early-stage data from gene therapy

Reuters
·
18 Feb

Solid Biosciences Shares Rise After Positive Trial Data for SGT-003 in Duchenne MD

Dow Jones
·
18 Feb

Morning Brew: Marjorie Taylor Greene's Stock Moves and Solid Biosciences' Surge

GuruFocus
·
18 Feb

Solid Bio Surges 86% After Trial Data for Lead Asset in Duchenne

Seeking Alpha
·
18 Feb

Solid Biosciences 35.74M share Spot Secondary priced at $4.03

TIPRANKS
·
18 Feb

BRIEF-Solid Biosciences Announces Pricing Of Underwritten Offering

Reuters
·
18 Feb

Solid Biosciences Inc - Prices Offering of 35.7 Mln Shares at $4.03/Share

THOMSON REUTERS
·
18 Feb

Solid Biosciences Announces Pricing of Underwritten Offering

THOMSON REUTERS
·
18 Feb

Solid Biosciences Announces Pricing of Underwritten Offering

GlobeNewswire
·
18 Feb

BRIEF-Solid Biosciences Reports Positive Initial Clinical Data from SGT-003

Reuters
·
18 Feb

Solid Biosciences Inc - Average Microdystrophin Expression of 110% Observed in Phase 1/2 Trial of Sgt-003

THOMSON REUTERS
·
18 Feb

Solid Biosciences - Plans to Request FDA Meeting for Accelerated Approval Pathway in Mid-2025 for Sgt-003

THOMSON REUTERS
·
18 Feb

Solid Biosciences Inc: Sgt-003 Has Been Well-Tolerated With No Serious Adverse Events Observed

THOMSON REUTERS
·
18 Feb

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

GlobeNewswire
·
18 Feb

Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks

TipRanks
·
09 Feb

Positive Outlook for Solid Biosciences: Anticipated Trial Data and Gene Therapy Platform Drive Buy Rating

TIPRANKS
·
05 Feb

Solid Biosciences reports inducement grants under Nasdaq listing rule

TIPRANKS
·
04 Feb

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Feb

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
04 Feb